Intrasense SA
Intrasense operates with a negative equity position of EUR -6.84 million and a cash balance of EUR 797,460, indicating a liquidity risk with a current ratio of 0.87. The enterprise value to revenue ratio of 6.73 suggests a premium valuation relative to its EUR 2.96 million revenue, but the negative EBITDA of EUR -10.68 million results in an EV/EBITDA of -1.87, signaling financial stress. Profitability metrics are mixed: a return on equity of 1.58% is positive but modest, while a return on assets of -1.35% reflects underperformance in asset utilization. Gross profit of EUR 4.44 million is offset by operating and net losses of EUR -10.68 million and EUR -10.81 million, respectively, indicating operational inefficiencies. The company's revenue is concentrated in three divisions: software, peripheral solutions, and services. No geographic breakdown is provided, but the EUR 2.96 million revenue is entirely attributed to disclosed segments. The lack of geographic diversification may increase exposure to regional market risks. Outlook data is not provided, but the EUR 3.305 billion revenue reported in IR observations suggests a significant discrepancy with the EUR 2.96 million in the financial snapshot. This inconsistency raises questions about the accuracy of forward-looking guidance or the comparability of reporting periods. Risk factors include a negative net cash position and a debt-to-equity ratio of -1.36, indicating a high reliance on debt financing. The risk assessment flags liquidity as medium and dilution as low, but the negative equity position suggests potential for future dilution if capital is raised. Recent events include a reported EPS of -EUR 0.07, consistent with the net loss of EUR -10.81 million. No recent filings or transcripts are provided to contextualize operational or strategic changes.
Business. Intrasense SA designs and develops 2D and 3D medical imaging software and peripheral solutions for computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) scans, generating revenue through software sales, peripheral solutions, and services.
Classification. Intrasense is classified in the Healthcare sector under Advanced Medical Equipment & Technology with 92% confidence, per verified market data.
- Intrasense has a negative equity position and operates at a loss, indicating financial distress.
- The company's EV/EBITDA of -1.87 and EV/Revenue of 6.73 suggest a premium valuation despite poor profitability.
- Revenue is concentrated in three divisions, with no geographic diversification disclosed.
- A negative net cash position and high debt-to-equity ratio signal liquidity and solvency risks.
- Discrepancies between reported revenue figures raise concerns about data consistency and transparency.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.